Literature DB >> 18689427

Translational medicine and the NIHR Biomedical Research Centre concept.

K Snape1, R C Trembath, G M Lord.   

Abstract

The realization of scientific discovery being delivered to patients for their clinical benefit is termed Translational Medicine. This requires the bridging of excellence in both basic scientific endeavour and clinical care. Whilst there is consensus that it is important to drive translation for the benefit of patient care, the mechanism whereby this is to be achieved is less clear. In this article, we describe a novel strategy for the realization of effective translation that encompasses capacity building, a flexible proof of concept in man and the creation of a translational faculty adjacent to clinical research facilities that forms the basis of our NIHR Comprehensive Biomedical Research Centre. The opportunity to deliver world-class biomedical research from within the UK has never been greater.

Entities:  

Mesh:

Year:  2008        PMID: 18689427     DOI: 10.1093/qjmed/hcn100

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

1.  Unraveling the autoimmune translational research process layer by layer.

Authors:  Richard S Blumberg; Bonnie Dittel; David Hafler; Matthias von Herrath; Frank O Nestle
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

2.  Implementation of collaborative governance in cross-sector innovation and education networks: evidence from the National Health Service in England.

Authors:  Pavel V Ovseiko; Catherine O'Sullivan; Susan C Powell; Stephen M Davies; Alastair M Buchan
Journal:  BMC Health Serv Res       Date:  2014-11-08       Impact factor: 2.655

3.  Maximising value from a United Kingdom Biomedical Research Centre: study protocol.

Authors:  Trisha Greenhalgh; Pavel V Ovseiko; Nick Fahy; Sara Shaw; Polly Kerr; Alexander D Rushforth; Keith M Channon; Vasiliki Kiparoglou
Journal:  Health Res Policy Syst       Date:  2017-08-14

Review 4.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

Review 5.  Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research.

Authors:  Nina Fudge; Euan Sadler; Helen R Fisher; John Maher; Charles D A Wolfe; Christopher McKevitt
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.